Business Context and Reporting Period
Company: MaxCyte, Inc. (MXCT)
Filing Type: Form 8-K (Current Report)
Date of Report: June 25, 2025
Reporting Period: Single event date (June 25, 2025)
MaxCyte, Inc., a Delaware corporation and emerging growth company, filed this report to disclose a corporate action regarding its international listing status. The company is headquartered in Rockville, Maryland, and its common stock trades on the Nasdaq Global Select Market.
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes
The primary material change disclosed is the voluntary delisting of the Company's common stock from the AIM market of the London Stock Exchange (LSE).
- Action: Application submitted to cancel admission of shares to trading on AIM.
- Effective Date: Expected to become effective at 7:00 a.m. U.K. time on June 26, 2025.
- Last Trading Day on AIM: June 25, 2025.
- Impact on U.S. Listing: No impact on the Nasdaq listing; shares will continue to trade under the ticker symbol MXCT.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies beyond the specific event of the AIM delisting. No unusual items were reported.
Investor Verification Checklist
- Confirm the final trading date for shares on the London Stock Exchange AIM market (June 25, 2025).
- Verify that trading continues uninterrupted on the Nasdaq Global Select Market under ticker MXCT.
- Review subsequent filings for any impact on the company's investor base or liquidity resulting from the removal of the London listing.